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CORRESPONDENCE
Shigella boydii as Cause of Malacoplakia in a
Human Immunodeficiency Virus–Infected Patient
SIR—We read with great interest the report by Raguin et al.
[1] on Shigella boydii as a possible causative agent of colonic
malacoplakia in an HIV-infected patient. In the absence of
positive cultures, S. boydii was identified by means of universal
bacterial 16S rDNA–based amplification and sequencing. Since
malacoplakia is usually caused by Escherichia coli, a close rel-
ative of shigellae and genetically belonging to the same species
(!), despite being classified in 2 separate genera for reasons of
different clinical and epidemiological significance, the reliable
separation of these 2 organisms would be essential to accepting
the conclusion made by the authors. On the basis of the data
presented (highest relatedness of the sequence detected to S.
boydii, with 459 [98%] of 468 nucleotides being identical) and
the analysis shown below, this does not seem possible.
When the fragment of the S. boydii 16S rRNA gene amplified
with primers 91E and 13B [2, 3] is compared with the corre-
sponding sequences deposited in the EMBL/Genebank data-
bases, no differences at all are found between it and several
other members of the family Enterobacteriaceae, including E.
coli, Escherichia vulneris, Salmonella paratyphi A, Salmonella
weltevreden, Shigella sonnei, Shigella flexneri, and Hafnia alvei.
Above the 98% identity level, there are also other organisms,
such as Klebsiella planticola and Citrobacter diversus. Further-
more, intraspecies variation of 16S sequences has been de-
scribed for various organisms [4, 5].
This illustrates that several species and genera within the
family Enterobacteriaceae are so closely related to each other
that their identification solely on the basis of partial sequences
of their 16S rRNA genes is certainly not conclusive, even if the
amplified fragments are repeatedly sequenced in both direc-
tions, thus resulting in absolutely reliable sequence data.
On the basis of the above considerations, we think that it is
rather unlikely (though not impossible) that malacoplakia in
the patient described was indeed caused by S. boydii.
Martin Altwegg and Hans Peter Hinrikson
Department of Medical Microbiology, University of Zurich,
Zurich, Switzerland
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Reply
SIR—Altwegg and Hinrikson, in their letter, question the con-
clusion in our report that Shigella boydii may be the causative
agent of malakoplakia. We agree that the fragment of the 16S
rRNA gene amplified with primers 91E and 13B does not per-
mit sequences of several members of the family Enterobacter-
iaceae to be distinguished reliably.
At the time of writing our report, the BLAST search version
we used (BLASTN 1.4.9 MP 26 h1996) gave the highest score
of homology for S. boydii, closely followed by Shigella sonnei,
Shigella flexneri, Hafnia alvei, and Escherichia coli. We agree
that the subtle differences given by the alignment search tool
should have been interpreted more cautiously. However, since
then, we have used the Microseq 16S rRNA Gene Kit (Perkin-
Elmer, Applied Biosystems, Foster City, CA) to amplify the
first 500 bp in the 5′ region of the bacterial 16S rDNA gene,
which allows discrimination between S. boydii and E. coli. The
DNA extracted from the malakoplakia tissue was confirmed
to contain a 16S rDNA sequence giving the highest genetic
relatedness with S. boydii 16S sequences and demonstrating 7
bp of difference from E. coli 16S rDNA sequences in discrim-
inant codons.
On the basis of these data, we think that it is probable
(though not certain) that malakoplakia in the patient described
was caused by S. boydii.
Gilles Raguin,1 Judith Nemeth,2 Michel Wassef,2
Jean Aerts,1 Marcelo Salmeron,3 Nicole Desplaces,3
and Laurent Belec3
1Hoˆpital de la Croix-Saint-Simon, 2Hoˆpital Lariboisie`re, and 3Hoˆpital
Broussais, Paris, France
Reprints or correspondence: Dr. Gilles Raguin, Hopital de la Croix-Saint-
Simon, 125 rue d’Avron, 75960 Paris Cedex 20, France (graguin@croix-saint-
simon.org).
Clinical Infectious Diseases 1999;29:1602
q 1999 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/1999/2906-0063$03.00
